Correction

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer

Correction Details

Retraction Reason:

Error in Text

Nature of Retraction:

Correction

Retraction Notice:
10.1200/JCO.2010.30.2323

Citations (92)

92
Total Citations
36
Post-Retraction
(39.1%)
50
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
10 Within 1 year
17 After 2+ years
4171 Days since retraction (latest)
Paper citing A genomic approach to identify molecular pathways ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Nov 2021
4171 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jul 2021
4048 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Sep 2019
3379 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jan 2019
3153 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: May 2018
2891 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Jun 2017
2571 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Sep 2016
2285 days after retraction
Paper citing Selective killing of cancer cells by a small molec...
Unknown Authors
Unknown Journal
Published: Sep 2016
2284 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Feb 2015
1706 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jul 2014
1520 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Nov 2013
1256 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Aug 2013
1176 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: May 2013
1077 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Apr 2013
1035 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Feb 2013
976 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Dec 2012
914 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Jun 2012
756 days after retraction
Paper citing An integrated genomic-based approach to individual...
Unknown Authors
Unknown Journal
Published: May 2012
709 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Mar 2012
654 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Mar 2012
639 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Sep 2011
457 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Sep 2011
457 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Aug 2011
428 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Aug 2011
426 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jul 2011
395 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Jun 2011
375 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: May 2011
334 days after retraction
Paper citing An integrated genomic-based approach to individual...
Unknown Authors
Unknown Journal
Published: Mar 2011
293 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Jan 2011
240 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Jan 2011
224 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Dec 2010
197 days after retraction
Paper citing Characterizing the Clinical Relevance of an Embryo...
Unknown Authors
Unknown Journal
Published: Oct 2010
122 days after retraction
Paper citing Phase II study of the anti-insulin-like growth fac...
Unknown Authors
Unknown Journal
Published: Sep 2010
92 days after retraction
Paper citing Genomic signatures to guide the use of chemotherap...
Unknown Authors
Unknown Journal
Published: Sep 2010
92 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Aug 2010
61 days after retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Jun 2010
24 days after retraction
Paper citing A Genomic Strategy to Refine Prognosis in Early-St...
Unknown Authors
Unknown Journal
Published: Apr 2010
59 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Mar 2010
63 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Mar 2010
78 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Mar 2010
92 days before retraction
Paper citing An integrated genomic-based approach to individual...
Unknown Authors
Unknown Journal
Published: Jan 2010
137 days before retraction
Paper citing An integrated genomic-based approach to individual...
Unknown Authors
Unknown Journal
Published: Jan 2010
138 days before retraction
Paper citing A genomic approach to identify molecular pathways ...
Unknown Authors
Unknown Journal
Published: Dec 2009
182 days before retraction
Paper citing Pharmacogenomic strategies provide a rational appr...
Unknown Authors
Unknown Journal
Published: Dec 2009
182 days before retraction
Related Records

This article has multiple records in the database due to different notices:

Record #3576
Dec 10, 2010
Retraction
Quick Stats
Total Citations: 92
Years Since Retraction: 15.5 years
Open Access: Yes
Last Checked: Never
Related Papers
Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melano…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 74 citations
Resistance to CDK4/6 inhibitors (CDK4/6i): The clinical use…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 0 citations
Usefulness of assessment of circulating tumor DNA(ctDNA) of…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 2 citations
Usefulness of assessment of circulating tumor DNA(ctDNA) of…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 2 citations
Resistance to CDK4/6 inhibitors (CDK4/6i): The clinical use…
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology • 0 citations